Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Active, not recruiting	Phase 2	2026-03-12		NCT04417621

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis Pharmaceuticals	432

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana Farber Cancer Institute	Boston	United States	300
Florida Cancer Specialists	Fort Myers	United States	15
H Lee Moffitt Cancer Center and Research Institute	Tampa	United States	11
Massachusetts General Hospital	Boston	United States	1015
Mayo Clinic Mayo Rochester	Rochester	United States	1
Mayo Clinic Rochester	Rochester	United States	133
Memorial Sloan Kettering	New York	United States	5
NYU Laura and Isaac Perlmutter Cancer Center	New York	United States	3
The Angeles Clinic and Research Institute	Los Angeles	United States	16
UCSF Medical Center	San Francisco	United States	26
Univ of TX MD Anderson Cancer Cntr	Houston	United States	4
University of Pittsburgh Med Center	Pittsburgh	United States	1